Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model

Bioconjugate Chemistry

Volumn 8, Issue 4, 1997, Pages 595-604

  Sharkey, Robert M ^a,c   Karacay, Habibe ^b   Griffiths, Gary L ^b   Behr, Thomas M ^a   Blumenthal, Rosalyn D ^a   Mattes, M Jules ^a   Hansen, Hans J ^b   Goldenberg, David M ^a  

^a GARDEN STATE CANCER CENTER   (United States)

^b IMMUNOMEDICS INC   (United States)

^c GSCC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; BINDING SITES; BLOOD; COENZYMES; DISEASES; MONOCLONAL ANTIBODIES;

CARCINOEMBRYONIC ANTIGEN; CONDITION; HUMAN COLON CANCER; IDIOTYPE; MURINE MONOCLONAL ANTIBODY; RADIOIMMUNOTHERAPY; SPECIFIC ACTIVITY; STREPTAVIDIN; TUMOR DOSE; TUMOR UPTAKE;

TUMORS;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS MUSCULUS;

EID: 0031193474     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970101v     Document Type: Article

References (33)

1. 131I-labeled monoclonal antibodies. Cancer Res. 52, 6036-6044.
2. Sharkey, R. M., Blumenthal, R. D., Hansen, H. J., and Goldenberg, D. M. (1990) Biological considerations for radioimmunotherapy. Cancer Res. 50 (Suppl.) 964s-969s.
3. 2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large colon carcinoma grafted in nude mice. J. Nucl. Med. 31, 1035-1044.
4. Sharkey, R. M., Blumenthal, R. D., Behr, T. M., Wong, G., Haywood, L., Forman, D., Griffiths, G., and Goldenberg, D. M. (1997) Selection of radioimmunconjugates for the therapy of well-established or micrometastatic colon carcinoma. Int. J. Cancer (in press).
5. Behr, T. M., Sharkey, R. M., Juweid, M. E., Blumenthal, R. D., Dunn, R. M., Griffiths, G. L., Wolf, F. G., Becker, W. S., and Goldenberg, D. M. (1995) Reduction of the renal uptake of radiolabeled monoclonal antibody fragments by cationic amino acids and their derivatives. Cancer Res. 55, 3825-3834.
6. 177Lu]α-[2-(4-aminophenyl)ethyl]-1,4,7,10-tetraaza-cyclodecane- 1,4,7,10-tetraacetic acid-CC49 Fab radioimmunoconjugate. Cancer Res. 55, 5288-5295.
7. 99mTc-labeled anti-Tac disulfide-stabilized Fv fragment. Cancer Res. 56, 3788-3795.
8. Behr, T. M., Sharkey, R. M., Sgouros, G., Blumenthal, R. D., Dunn, R. M., Kolbert, K., Griffiths, G. L., Siegel, J. A., Becker, W. S., and Goldenberg, D. M. (1997) Improved cancer therapy by overcoming nephrotoxicity of radiometal-labeled immunoconjugates and peptides: biological effects in relation to internal radiation dosimetry in a human colon cancer model. Cancer (in press).
9. Blumenthal, R. D., Fand, I., Sharkey, R. M., Boerman, O. C., Kashi, R., and Goldenberg, D. M. (1991) The effect of antibody protein dose of tumor distribution of radiolabeled antibodies: an autoradiographic study. Cancer Immunol. Immunother. 33, 351-358.
10. Fujimori, K., Covell, D. G., Fletcher, J. E., and Weinstein, J. N. (1989) Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab′)2, and Fab in tumors. Cancer Res. 49, 5656-5663.
11. Sharkey, R. M., Primus, F. J., and Goldenberg, D. M. (1984) Second antibody clearance of radiolabeled antibody in cancer radioimmunodetection. Proc. Natl. Acad. Sci. U.S.A. 81, 2843-2846.
12. Sharkey, R. M., Boerman, O. C., Natale, A., Pawlyk, D., Monestier, M., Losman, M. J., and Goldenberg, D. M. (1992) Enhanced clearance of radiolabeled murine monoclonal antibody by a syngeneic anti-idiotype antibody in tumor-bearing nude mice. Int. J. Cancer 51, 266-273.
13. Goodwin, D., Meares, C., Diamanti, C., McCall, M., Lai, C., Torti, F., McTigue, M., and Martin, B. (1984) Use of specific antibody for rapid clearance of circulating blood background from radiolabeled tumor imaging proteins. Eur. J. Nucl. Med. 29, 226-243.
14. Begent, R. H. J., Ledermann, J. A., Green, A. J., Bagshawe, K. D., Riggs, S. J., Searle, F., Keep, P. A., Adam, T., Dale, R. G., and Glaser, M. G. (1989) Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. Br. J. Cancer 60, 406-412.
15. Pedley, R. B., Dale, R., Boden, J. A., Begent, R. H. J., Keep, P. A., and Green, A. J. (1989) The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model. Int. J. Cancer 43, 713-718.
16. Blumenthal, R. D., Sharkey, R. M., and Goldenberg, D. M. (1995) Overcoming Dose-Limiting, Radioantibody-Induced Myelotoxicity. In Cancer Therapy with Radiolabeled Antibodies (D. M. Goldenberg, Ed.) pp. 295-314, CRC Press, Boca Raton, FL.
17. Norrgren, K., Strand, S.-E., Nilsson, R., Lindgren, L., and Sjögren, H.-O. (1993) A general, extracorporeal immunoadsorption method to increase the tumor-to-normal tissue ratio in radioimaging and radioimmunotherapy. J. Nucl. Med. 34, 448-454.
18. Lear, J. L., Kasliwal, R. K., Feyerabend, A. J., Pratt, J. P., Bunn, P. A., Dienhar, D. G., Gonsaly, R., Johnson, T. K., Bloedow, D. C., Maddock, S. W., and Glenn, S. D. (1991) Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column. Radiology 179, 509-512.
19. Goodwin, D. A., and Meares, C. F. (1997) Pretargeting: General principles. Cancer (in press).
20. 90Y radioimmunotherapy in a mouse xenograft model. J. Immunother. 16, 158 (abstract).
21. Karacay, H., Sharkey, R. M., Griffiths, G. L., Govindan, S. V., McBride, W. J., Goldenberg, D. M., and Hansen, H. J. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, Radiolabeled Biotion pretargeting method for radioimmunotherapy of colorectal cancer. Reagent Development. Bioconjugate Chem. 8, 585-594.
22. Hansen, H. J., Goldenberg, D. M., Newman, E. S., Grebenau, R., and Sharkey, R. M. (1993) Characterization of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer 71, 3478-3485.
23. Goldenberg, D. M., and Hansen, H. J. (1972) Carcinoembryonic antigen present in human colonie neoplasms serially propaged in hamsters. Science 175, 1117-1118.
24. Sharkey, R. M., Motta-Hennessy, C., Pawlyk, D., Siege, J. A., and Goldenberg, D. M. (1990) Biodistribution and radiation dose estimates for yttrium-and iodine-labeled monoclonal antibody IgG and fragments in nude mice bearing human colonic tumor xeongrafts. Cancer Res. 50, 2330-2336.
25. Sharkey, R. M., Primus, F. J., and Goldenberg, D. M. (1987) Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts. Int. J. Cancer 39, 611-617.
26. Boerman, O. C., Sharkey, R. M., Wong, G. Y., Blumenthal, R. D., Aninipot, R. L., and Goldenberg, D. M. (1992) Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumors. Cancer Immunol. Immunother. 35, 127-134.
27. Mattes, M. J. (1987) Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modification. J. Natl. Cancer Inst. 79, 855-863.
28. Rosebrough, S. F., and Hartley, D. F. (1995) Quantification and lowering of serum biotin. Lab. Anim. Sci. 45, 554-557.
29. Rosebrough, S. F. (1993) Pharmacokinetics and biodistribution of radiolabeled avidin, streptavidin, and biotin. Nucl. Med. Biol. 20, 663-668.
30. Hnatowich, D. J. (1994) The in vivo uses of streptavidin and biotin: a short progress report. Nucl. Med. Commun. 15, 575-577.
31. Kalofonos, H. P., Rusckowski, M., Siebecker, D. A., Sivolapenko, G. B., Snook, D., Lavender, J. P., Epenetos, A. A., and Hnatowich, D. J. (1990) Imaging of tumor in patients with indium-111-labeled biotin and streptavidin-conjugated antibodies: Preliminary communication. J. Nucl. Med. 31, 1791-1796.
32. Axworthy, D. B., Beaumier, P. L., Bottino, S., Goshorn, R. W., Mallett, R. W., Stone, D. M., Su, F.-M., Theodore, L. J., Yau, E. K., and Reno, J. M. (1996) Preclinical optimization of pretargeted radioimmunotherapy components: High efficiency, curative 90Y delivery to mouse tumor xenografts. Tumor Targeting 2, 156-157 (abstract).
33. O'Connor, S. W., and Bale, W. F. (1984) Accessibility of circulating immunoglobulin G to the extravascular compartment of solid rat tumors. Cancer Res. 44, 3719-3723.